Classification ![]() |
|
| Compound class | Antibody |
| Approved drug? | Yes (source: FDA (2003)) |
| Withdrawn drug? | Yes |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8059 | alefacept |
Synonyms ![]() |
| Amevive® |
| BG 9273 |
| BG 9712 |
| BG-9273 |
| BG-9712 |
| Lfa3Tip |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 215 |
| Other databases | |
| CAS Registry No. | 222535-22-0 |
| ChEMBL Ligand | CHEMBL1201571 |
| DrugBank Ligand | DB00092 |
| PubChem SID | 135340378 |
| Search PubMed clinical trials | alefacept |
| Search PubMed titles | alefacept |
| Search PubMed titles/abstracts | alefacept |
| Wikipedia | Alefacept |
| Comments |
| This is a fusion protein of the CD2 ligand (CD58/LFA3, lymphocyte function associated antigen 3) linked to the Fc domain of IgG1. The construct is called LFA3TIP in [2]. |